Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000891839-20-000016
Filing Date
2020-01-06
Accepted
2020-01-06 16:32:01
Documents
1
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 4393
  Complete submission text file 0000891839-20-000016.txt   5794
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620
Business Address
Van Strydonck, Gerald E. (Reporting) CIK: 0001748247 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38624 | Film No.: 20510160